A Phase I/IIa Sporozoite Challenge Study to Assess the Protective Efficacy of Two Prime-boost Malaria Vaccine Candidates: ChAd63 and MVA encoding ME-TRAP and the same Viral Vectors encoding CS
Phase of Trial: Phase I/II
Latest Information Update: 12 Oct 2014
At a glance
- Drugs ME-TRAP malaria DNA vaccine Okairos (Primary) ; Malaria vaccine
- Indications Malaria
- Focus Therapeutic Use
- 01 Nov 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 29 Oct 2012 Accrual to date is 100% according to United Kingdom Clinical Research Network.
- 01 Oct 2012 New source identified and integrated (UK Clinical Research Network, 13180).